Intro

This chapter explores the revolutionary CRISPR technology and its potential for advancing genetic therapies. It also addresses the evolving financial dynamics between healthcare systems and drug companies, highlighting the challenges and opportunities for innovators in this field.

Play episode from 00:00

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app